Meeting Coverage
ASH Video Pearls: ALL
Video Pearls from the American Society of Hematology
Latest ASH Video Pearls: ALL Meeting Coverage
3-year disease-free survival rate was 96% with blinatumomab versus 87.9% with chemo alone
December 30, 2024
Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed
December 23, 2024
Researchers also examined MRD to guide treatment decisions, and other personalized approaches
December 18, 2024
Latest Oncology/Hematology Meeting Coverage
-
GuCS: Genitourinary Cancers Symposium
February 2025
-
GICS: Gastrointestinal Cancers Symposium
January 2025
-
SABCS: San Antonio Breast Cancer Symposium
December 2024
-
ASH: Hematology: American Society of Hematology
December 2024